Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,444 | 800 | 99.3% |
| Education | $74.50 | 11 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,483 | 172 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,457 | 102 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,275 | 102 | $0 (2024) |
| Lundbeck LLC | $785.35 | 61 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $750.61 | 47 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $745.50 | 31 | $0 (2024) |
| Alkermes, Inc. | $634.71 | 62 | $0 (2024) |
| Corium, LLC | $500.24 | 52 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $410.17 | 38 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $355.71 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,639 | 195 | ABBVIE INC. ($538.27) |
| 2023 | $2,942 | 235 | Janssen Pharmaceuticals, Inc ($494.32) |
| 2022 | $2,837 | 219 | Otsuka America Pharmaceutical, Inc. ($719.11) |
| 2021 | $2,099 | 162 | Otsuka America Pharmaceutical, Inc. ($333.92) |
All Payment Transactions
811 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/19/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $21.28 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: CNS | ||||||
| 12/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: ADHD | ||||||
| 12/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.10 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $14.77 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $8.73 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $1.75 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Neuropsychiatry | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.15 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $17.49 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 87 | 339 | $62,037 | $22,578 |
| 2022 | 1 | 100 | 407 | $74,481 | $28,582 |
| 2021 | 3 | 188 | 388 | $62,305 | $26,466 |
| 2020 | 5 | 250 | 385 | $38,607 | $13,164 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 339 | $62,037 | $22,578 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 407 | $74,481 | $28,582 | 38.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 251 | $45,933 | $20,151 | 43.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 123 | $15,252 | $5,740 | 37.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 14 | 14 | $1,120 | $575.17 | 51.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 87 | 133 | $7,140 | $3,856 | 54.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 80 | 127 | $15,748 | $3,563 | 22.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 42 | 63 | $11,529 | $3,336 | 28.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 25 | 35 | $2,990 | $1,865 | 62.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 16 | 27 | $1,200 | $544.61 | 45.4% |
About Michael Dunker, PMHNP-BC
Michael Dunker, PMHNP-BC is a Psychiatric/Mental Health healthcare provider based in Troy, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2019. The National Provider Identifier (NPI) number assigned to this provider is 1487215604.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Dunker, PMHNP-BC has received a total of $10,518 in payments from pharmaceutical and medical device companies, with $2,639 received in 2024. These payments were reported across 811 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($10,444).
As a Medicare-enrolled provider, Dunker has provided services to 625 Medicare beneficiaries, totaling 1,519 services with total Medicare billing of $90,790. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Troy, OH
- Active Since 06/27/2019
- Last Updated 02/06/2023
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487215604
Products in Payments
- VRAYLAR (Drug) $1,483
- INVEGA SUSTENNA (Drug) $1,274
- ABILIFY MAINTENA (Drug) $1,154
- REXULTI (Drug) $877.80
- INGREZZA (Drug) $745.50
- ARISTADA (Drug) $562.16
- LATUDA (Drug) $410.17
- CAPLYTA (Drug) $379.41
- Auvelity (Drug) $338.21
- Austedo XR (Drug) $329.73
- Azstarys (Drug) $321.50
- HETLIOZ (Drug) $314.47
- Dyanavel XR (Drug) $301.01
- TRINTELLIX (Drug) $285.11
- JORNAY PM (Drug) $283.35
- AUSTEDO (Drug) $268.97
- ABILIFY ASIMTUFII (Drug) $188.56
- AZSTARYS (Drug) $178.74
- PERSERIS (Drug) $162.55
- QELBREE (Drug) $154.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Troy
Mary Halloran-Ruhle, Npp, NPP
Psychiatric/Mental Health — Payments: $15,585
Mrs. Jeanne Davis, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $14,368
Mrs. Laurie Lavin
Psychiatric/Mental Health — Payments: $14,086
Jacquelyn Terry, Rn-Bsn, Pmhnp-Bc, RN-BSN, PMHNP-BC
Psychiatric/Mental Health — Payments: $5,642
Samantha Lucca, Np, NP
Psychiatric/Mental Health — Payments: $5,577
Diana Vitale, Np, NP
Psychiatric/Mental Health — Payments: $4,283